
### [NCIT:C7233](http://purl.obolibrary.org/obo/NCIT_C7233)
**Label:** Monomorphic Post-Transplant Lymphoproliferative Disorder

**Subclasses:** [NCIT:C7249](http://purl.obolibrary.org/obo/NCIT_C7249) (Immunoblastic Lymphoma Post-Transplant Lymphoproliferative Disorder), [NCIT:C7238](http://purl.obolibrary.org/obo/NCIT_C7238) (Monomorphic T/NK-Cell Post-Transplant Lymphoproliferative Disorder), [NCIT:C7248](http://purl.obolibrary.org/obo/NCIT_C7248) (Centroblastic Lymphoma Post-Transplant Lymphoproliferative Disorder), [NCIT:C7237](http://purl.obolibrary.org/obo/NCIT_C7237) (Monomorphic B-Cell Post-Transplant Lymphoproliferative Disorder), [NCIT:C7245](http://purl.obolibrary.org/obo/NCIT_C7245) (Burkitt-Like Lymphoma Post-Transplant Lymphoproliferative Disorder), [NCIT:C7244](http://purl.obolibrary.org/obo/NCIT_C7244) (Burkitt Lymphoma Post-Transplant Lymphoproliferative Disorder), [NCIT:C7247](http://purl.obolibrary.org/obo/NCIT_C7247) (Anaplastic Lymphoma Post-Transplant Lymphoproliferative Disorder), [NCIT:C7246](http://purl.obolibrary.org/obo/NCIT_C7246) (Diffuse Large B-Cell Lymphoma Post-Transplant Lymphoproliferative Disorder), [NCIT:C7241](http://purl.obolibrary.org/obo/NCIT_C7241) (Plasmacytoma-Like Post-Transplant Lymphoproliferative Disorder), [NCIT:C7240](http://purl.obolibrary.org/obo/NCIT_C7240) (Plasma Cell Post-Transplant Lymphoproliferative Disorder), [NCIT:C7242](http://purl.obolibrary.org/obo/NCIT_C7242) (Plasma Cell Myeloma Post-Transplant Lymphoproliferative Disorder), 

**Class expressions from DL-Learner:**

- Thing 53.22%
- [CL:0000786](http://purl.obolibrary.org/obo/CL_0000786) (plasma cell) 40.36%
- [CL:0000786](http://purl.obolibrary.org/obo/CL_0000786) (plasma cell) and (not ([NCIT:C39069](http://purl.obolibrary.org/obo/NCIT_C39069) (ErbB3 Receptor Recycling Pathway))) 40.36%
- [CL:0000786](http://purl.obolibrary.org/obo/CL_0000786) (plasma cell) and (not ([NCIT:C39067](http://purl.obolibrary.org/obo/NCIT_C39067) (EPO Signaling Pathway))) 40.36%
- [CL:0000786](http://purl.obolibrary.org/obo/CL_0000786) (plasma cell) and (not ([NCIT:C39066](http://purl.obolibrary.org/obo/NCIT_C39066) (Erythropoietin Neuroprotection Pathway))) 40.36%
- [CL:0000786](http://purl.obolibrary.org/obo/CL_0000786) (plasma cell) and (not ([NCIT:C39059](http://purl.obolibrary.org/obo/NCIT_C39059) (Map Kinase Inactivation of SMRT Corepressor Pathway))) 40.36%
- [CL:0000786](http://purl.obolibrary.org/obo/CL_0000786) (plasma cell) and (not ([NCIT:C39058](http://purl.obolibrary.org/obo/NCIT_C39058) (EGF Signaling Pathway))) 40.36%
- [CL:0000786](http://purl.obolibrary.org/obo/CL_0000786) (plasma cell) and (not ([NCIT:C39056](http://purl.obolibrary.org/obo/NCIT_C39056) (Vesicle Transport Pathway))) 40.36%
- [CL:0000786](http://purl.obolibrary.org/obo/CL_0000786) (plasma cell) and (not ([NCIT:C39055](http://purl.obolibrary.org/obo/NCIT_C39055) (Phospholipid Signaling Pathway))) 40.36%
- [CL:0000786](http://purl.obolibrary.org/obo/CL_0000786) (plasma cell) and (not ([NCIT:C39054](http://purl.obolibrary.org/obo/NCIT_C39054) (Extracellular Matrix Binding Pathway))) 40.36%
- [CL:0000786](http://purl.obolibrary.org/obo/CL_0000786) (plasma cell) and (not ([NCIT:C39040](http://purl.obolibrary.org/obo/NCIT_C39040) (CTCF Pathway))) 40.36%
- [CL:0000786](http://purl.obolibrary.org/obo/CL_0000786) (plasma cell) and (not ([NCIT:C39021](http://purl.obolibrary.org/obo/NCIT_C39021) (Cell Migration Pathway))) 40.36%
- [CL:0000786](http://purl.obolibrary.org/obo/CL_0000786) (plasma cell) and (not ([NCIT:C39016](http://purl.obolibrary.org/obo/NCIT_C39016) (EGF Receptor Downregulation by CBL Pathway))) 40.36%
- [CL:0000786](http://purl.obolibrary.org/obo/CL_0000786) (plasma cell) and (not ([NCIT:C39013](http://purl.obolibrary.org/obo/NCIT_C39013) (Estrogen Receptor Regulation by CARM1 Pathway))) 40.36%
- [CL:0000786](http://purl.obolibrary.org/obo/CL_0000786) (plasma cell) and (not ([NCIT:C39011](http://purl.obolibrary.org/obo/NCIT_C39011) (Cardiac Hypertrophy Pathway))) 40.36%


